Pfizer Inc. (PFE)
28.46
+0.50
(+1.81%)
USD |
NYSE |
Aug 31, 16:00
28.53
+0.06
(+0.23%)
After-Hours: 20:00
Pfizer Cash from Operations (TTM) : 13.40B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.40B |
| March 31, 2026 | 11.98B |
| December 31, 2025 | 11.70B |
| September 30, 2025 | 13.08B |
| June 30, 2025 | 15.19B |
| March 31, 2025 | 13.99B |
| December 31, 2024 | 12.74B |
| September 30, 2024 | 11.26B |
| June 30, 2024 | 8.005B |
| March 31, 2024 | 8.58B |
| December 31, 2023 | 8.70B |
| September 30, 2023 | 12.04B |
| June 30, 2023 | 18.52B |
| March 31, 2023 | 27.90B |
| December 31, 2022 | 33.23B |
| September 30, 2022 | 30.56B |
| June 30, 2022 | 31.46B |
| March 31, 2022 | 34.58B |
| December 31, 2021 | 32.58B |
| September 30, 2021 | 32.29B |
| June 30, 2021 | 23.54B |
| March 31, 2021 | 15.82B |
| December 31, 2020 | 14.40B |
| September 30, 2020 | 12.55B |
| June 30, 2020 | 14.97B |
| Date | Value |
|---|---|
| March 31, 2020 | 14.02B |
| December 31, 2019 | 12.59B |
| September 30, 2019 | 13.56B |
| June 30, 2019 | 14.31B |
| March 31, 2019 | 15.54B |
| December 31, 2018 | 15.83B |
| September 30, 2018 | 18.16B |
| June 30, 2018 | 17.81B |
| March 31, 2018 | 17.19B |
| December 31, 2017 | 16.80B |
| September 30, 2017 | 15.48B |
| June 30, 2017 | 15.31B |
| March 31, 2017 | 15.68B |
| December 31, 2016 | 15.90B |
| September 30, 2016 | 14.86B |
| June 30, 2016 | 15.15B |
| March 31, 2016 | 15.64B |
| December 31, 2015 | 14.51B |
| September 30, 2015 | 15.20B |
| June 30, 2015 | 14.64B |
| March 31, 2015 | 14.63B |
| December 31, 2014 | 16.88B |
| September 30, 2014 | 17.27B |
| June 30, 2014 | 18.72B |
| March 31, 2014 | 18.46B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |
| Bristol Myers Squibb Co. | 12.78B |
| Viatris, Inc. | 2.331B |